GL1X · GenesisL1 explorer

MolNFT v1 · #68858 · protein

Crystal structure of susg

3K8K · Alpha-amylase, susg: “Crystal structure of susg”. X-ray diffraction, 2 ligands (MG, CA), 11 pockets (best druggability 0.63). MolNFT v1 #68858 on GenesisL1: 3D structure, binding sites and pockets in GL1X.

PDB
3K8K
Type
protein
Length
1,299 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Alpha-amylase, susg
UniProt
Q8A1G3
Ligands
MG, CA
Pockets
11 · best druggability 0.63

Structure

x-ray diffraction · 2 distinct chains · 27% helix, 23% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AAlpha-amylase, susgprotein65027% helix, 23% strandQ8A1G3
BAlpha-amylase, susgprotein64926% helix, 23% strandQ8A1G3

Ligands and binding sites

  • MG · Magnesium ion · metal · 2 copies · chains A, B
  • CA · Calcium ion · metal · 2 copies · chains A, B
  • EDO · 1,2-ethanediol · additive · 13 copies · chains A, B
  • ACT · Acetate ion · additive · 5 copies · chains A, B
  • PEG · Di(hydroxyethyl)ether · additive · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

11 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
15670.630.7549EDO
21560.460.7624EDO, ACT
31550.450.7625EDO, ACT
4850.390.7717empty
5970.380.7517empty

Interfaces

1 interface between chains.

  • A–B · 182 Ų buried · 2 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 22 modified (engineered).

Compared structures

  • 3K8K · Crystal structure of SusG · the same entry in another collection · chain A against A, TM-score 1.00
  • Q8A1G3 · AlphaFold monomer V2.0 prediction for alpha-amylase susg (Q8A1G3) · a predicted model of the same protein · chain B against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.